Simona Duranti

688 total citations
28 papers, 449 citations indexed

About

Simona Duranti is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Simona Duranti has authored 28 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Simona Duranti's work include Endometrial and Cervical Cancer Treatments (6 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (6 papers). Simona Duranti is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Genomics and Diagnostics (6 papers). Simona Duranti collaborates with scholars based in Italy, Malaysia and Japan. Simona Duranti's co-authors include Stefania Gori, Alessandro Inno, Giovanni Scambia, Monica Turazza, Domenica Lorusso, Gennaro Daniele, Lucio Crinò, Antonella Pietragalla, Camilla Nero and Francesca Ciccarone and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Molecular Sciences.

In The Last Decade

Simona Duranti

23 papers receiving 440 citations

Peers

Simona Duranti

ONCOL

PRM

PFM

Loredana Miglietta Italy

Christine Gennigens Belgium

Jane‐Chloé Trone France

In Ae Park South Korea

Karel Cwiertka Czechia

Naoki Ogane Japan

Valentina Tuninetti Italy

Susan B. Ingersoll United States

Loredana Miglietta Italy

Simona Duranti

296 ×1.3

ONCOL

116 ×0.8

PRM

145 ×1.3

137 ×1.3

54 ×0.6

PFM

Citations per year, relative to Simona Duranti Simona Duranti (= 1×) peers Loredana Miglietta

Countries citing papers authored by Simona Duranti

Since Specialization

Citations

This map shows the geographic impact of Simona Duranti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Duranti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Duranti more than expected).

Fields of papers citing papers by Simona Duranti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Duranti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Duranti. The network helps show where Simona Duranti may publish in the future.

Co-authorship network of co-authors of Simona Duranti

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Duranti. A scholar is included among the top collaborators of Simona Duranti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Duranti. Simona Duranti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nero, Camilla, Simona Duranti, Floriana Camarda, et al.. (2025). POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a large prospective single‐center cohort. Cancer. 131(3). e35731–e35731. 2 indexed citations

Capasso, Ilaria, Emanuele Perrone, Simona Duranti, et al.. (2025). Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience. European Journal of Cancer. 220. 115344–115344. 2 indexed citations

D’Alessandris, Nicoletta, Angela Santoro, Michele Valente, et al.. (2025). A Case Report to Reflect on the Origins of MMRd Mesonephric-like Ovarian Adenocarcinoma: Can It Be Defined as a Mϋllerian Neoplasm?. International Journal of Molecular Sciences. 26(11). 5245–5245.

Santoro, Angela, Damiano Arciuolo, Giulia Scaglione, et al.. (2025). 1066 NGS-MSI and IHC-MMR Concordance in Endometrial and Colorectal Cancers. Laboratory Investigation. 105(3). 103300–103300.

Marino, Ignazio R., Simona Duranti, Luciano Giacò, et al.. (2024). 60P Exploration of homologous recombination deficiency testing in ovarian cancer: Insight from an Italian referral center. ESMO Open. 9. 103567–103567.

Fabi, Alessandra, Laura Cortesi, Simona Duranti, et al.. (2024). Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2. Critical Reviews in Oncology/Hematology. 201. 104431–104431.

Capasso, Ilaria, Angela Santoro, Emanuela Lucci‐Cordisco, et al.. (2023). Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer. Cancers. 15(5). 1400–1400. 14 indexed citations

Falcone, Rosa, Pasquale Lombardi, Marco Filetti, et al.. (2022). Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years. Cancers. 14(4). 889–889. 18 indexed citations

Paris, Ida, Luisa Carbognin, Simona Duranti, et al.. (2022). PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives. Cancers. 14(9). 2161–2161. 27 indexed citations

10.

Nero, Camilla, Simona Duranti, Angelo Minucci, et al.. (2022). Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center. Journal of Personalized Medicine. 12(10). 1746–1746. 6 indexed citations

11.

Giacò, Luciano, Fernando Palluzzi, Davide Guido, et al.. (2022). A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants. Cancers. 14(24). 6152–6152. 6 indexed citations

12.

Pietragalla, Antonella, Simona Duranti, Gennaro Daniele, et al.. (2021). Oregovomab: an investigational agent for the treatment of advanced ovarian cancer. Expert Opinion on Investigational Drugs. 30(2). 103–110. 8 indexed citations

13.

Duranti, Simona, Antonella Pietragalla, Gennaro Daniele, et al.. (2021). Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data. Cancers. 13(9). 2089–2089. 29 indexed citations

14.

Duranti, Simona, Alessandra Fabi, Marco Filetti, et al.. (2021). Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials. Cancers. 13(20). 5198–5198. 10 indexed citations

15.

Nero, Camilla, Francesca Ciccarone, Antonella Pietragalla, et al.. (2021). Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors. Cancers. 13(6). 1298–1298. 30 indexed citations

16.

Gori, Stefania, Monica Turazza, Alessandra Modena, et al.. (2018). When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?. Critical Reviews in Oncology/Hematology. 128. 130–138. 7 indexed citations

17.

Foglietta, Jennifer, Alessandro Inno, Francesca De Iuliis, et al.. (2016). Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients. Clinical Breast Cancer. 17(1). 11–17. 57 indexed citations

18.

Bogina, Giuseppe, Enrico Munari, Marcella Marconi, et al.. (2015). Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome. Annals of Oncology. 26. vi137–vi137. 3 indexed citations

19.

Gori, Stefania, Gianluigi Lunardi, Alessandro Inno, et al.. (2014). Pharmacokinetics of Oxaliplatin in a Hemodialyzed Patient: Chemotherapy Dose Adjustment and Timing of Dialysis. Clinical Colorectal Cancer. 13(4). 260–263. 14 indexed citations

20.

Metro, Giulio, Rita Chiari, Simona Duranti, et al.. (2012). Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype. Lung Cancer. 78(1). 81–86. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact